We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


South Korean Stem Cell Firm Enters Into an Agreement with Tiantan Puhua Hospital in China

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "South Korean Stem Cell Firm Enters Into an Agreement with Tiantan Puhua Hospital in China"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

RNL Bio, Co., LTD., on Feb 4, 2008, has entered into an agreement with Beijing Tiantan Puhua Hospital (Puhua) in Beijing, China to establish a joint venture (the firm) and a new hospital to provide patients with stem cell therapeutics.

Dr. Sherwood Yang, Vice president of Puhua agreed with Dr. Jeong Chan Ra, president of CEO of RNL, to open a new stem cell clinic within Puhua hospital through the firm. The new hospital was tentatively named as "RNL-Puhua Stem Cell Medical Center, and will provide stem cell treatments of various degenerative disease including hair loss, aged face and osteoarthritis.

The firm will also supply Puhua hospital with stem cell therapeutics for neurological condition such as spinal cord injury which Puhua is specialized for.

"We are very pleased to have a new hospital for stem cell therapy in China. It will not only advance the commercialization of out stem cell technology but contribute effective stem cell treatment to patients with obsolete complications", said Dr. Ra.